General Infectious Disease News Articles

Infectious Dis.

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Nunn A et al. – The development of effective microbicide products remains one of the strongest hopes for new biomedical prevention tools. MDP301 is the largest Phase III microbicide trial to date, with 9404 enrolments, and is scheduled for completion in September 2009. Results are expected towards the end of 2009.

Related Articles

Effectiveness of Increasing Emergency Department Patients' Self-perceived Risk for Being Human Immunodeficiency Virus (HIV) Infected Through Audio Computer Self-interview–based Feedback About Reported HIV Risk Behaviors
Academic Emergency Medicine, 11/11/09    Relevance Score: 95%

HIV-Specific Health Care Utilization and Mortality among Tuberculosis/HIV Coinfected Persons
AIDS Patient Care and STDs, 10/06/09    Relevance Score: 95%

Mediators of HIV-related stigma and risk behavior in HIV infected young women
AIDS Care, 11/12/09    Relevance Score: 94%

Sperm May Play Leading Role In Spreading HIV
ScienceDaily, 10/27/09    Relevance Score: 94%

Female sex work and HIV risks in Croatia
AIDS Care, 10/29/09    Relevance Score: 93%

Today in OB/TORCH Infections...keeping you current

Novel H1N1 Virus Infection and Pregnancy
Postgraduate Medicine, 11/24/09

Maternal Lyme borreliosis and pregnancy outcome
International Journal of Infectious Diseases, 11/20/09

Bacterial vaginosis: an update on diagnosis and treatment
Expert Review of Anti-infective Therapy, 11/12/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address